✦ LIBER ✦

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report

✍ Scribed by Goldman, S; Smith, L; Anderson, J R; Perkins, S; Harrison, L; Geyer, M B; Gross, T G; Weinstein, H; Bergeron, S; Shiramizu, B; Sanger, W; Barth, M; Zhi, J; Cairo, M S

Book ID: 120541127
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 471 KB
Volume: 27
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2012.255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimal disease assessment in the treatm

Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children’s oncology group report

✍ Bruce Shiramizu; Stanton Goldman; Ian Kusao; Melissa Agsalda; James Lynch; Lynet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Excellent survival following two courses

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

✍ Mary Gerrard; Mitchell S. Cairo; Claire Weston; Anne Auperin; Ross Pinkerton; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Specific cytogenetic abnormalities are a

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

✍ Poirel, H A; Cairo, M S; Heerema, N A; Swansbury, J; Aupérin, A; Launay, E; Sang 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

Rituximab pharmacokinetics in children a

Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report

✍ Barth, Matthew J.; Goldman, Stanton; Smith, Lynette; Perkins, Sherrie; Shiramizu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Clinical characteristics and outcome ana

Clinical characteristics and outcome analysis of pediatric B-cell non-Hodgkin's lymphoma. Experience with FAB-LMB 96 and UKCCSG B-cell NHL guidelines in a developing country

✍ Naveed AHMAD; Alia ZAIDI; Farhana BADAR; Ata-ur-Rehman MAAZ; Muhammad S AKRAM 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Rituximab with chemotherapy in children

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

✍ Goldman, Stanton; Smith, Lynette; Galardy, Paul; Perkins, Sherrie L.; Frazer, Jo 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB